News Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congress™ 2022 and Provides AB-836 Clinical Update Staff June 25, 2022 Continue Reading Previous Immunocore announces the presentation of initial data from the Phase 1 ImmTAV® trial for chronic Hepatitis B at the EASL International Liver Congress™Next Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program More Stories Healthcare News Robotics Comcast, U.S. Conference of Mayors Announce Ten Cities Receiving Grants in Digital Equity Challenge Staff June 21, 2024 Cancer News Nursing Seniors Veterans C&N Teams Raise Over $98,000 for Local Senior Citizens Staff June 21, 2024 Healthcare News Rush University System for Health (RUSH) Advances its Supply Chain with Surgence™ Staff June 21, 2024